Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Our advice? Get a budget!

Matthew Brougham1, Scott Metcalfe, Wayne McNee

  • 1Analysis and Assessment, Pharmaceutical Management Agency, Auckland, New Zealand.

Healthcarepapers
|June 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of the incremental cost-effectiveness ratio for decision-making policies-what is the problem? A perspective paper.

Expert review of pharmacoeconomics & outcomes research·2022
Same author

Over and under? Ethnic inequities in community antibacterial prescribing.

The New Zealand medical journal·2019
Same author

Moving Towards Accountability for Reasonableness - A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case Study.

International journal of health policy and management·2019
Same author

Te Wero tonu-the challenge continues: Māori access to medicines 2006/07-2012/13 update.

The New Zealand medical journal·2018
Same author

Response to Cameron et al "Mind the graph" Semin Oncol. 2018.

Seminars in oncology·2018
Same author

The Zero Carbon Bill and the health of New Zealanders-help shape this crucial health law now.

The New Zealand medical journal·2018
Same journal

Building the Structures and Ecosystem Required for Sustainable Health Innovation in Canada.

HealthcarePapers·2026
Same journal

Is Health Canada the Key to Cracking the Nut of Healthcare Reform?

HealthcarePapers·2026
Same journal

Rethinking the Federal Role in Health: Revisiting the 2015 Naylor Report on Healthcare Innovation.

HealthcarePapers·2026
Same journal

Scaling Innovation in a Publicly Funded System: A UK Pathway From Evidence to Adoption.

HealthcarePapers·2026
Same journal

Accelerating Innovation and Technological Transformation on a National Scale.

HealthcarePapers·2026
Same journal

Beyond Silos and Perpetual Pilots: Data as the Catalyst for Canada's Healthcare Innovation Revolution.

HealthcarePapers·2026
See all related articles

To avoid healthcare bankruptcy, know your spending limits first. Operating within budget constraints, like setting drug subsidies, can achieve desired health outcomes more effectively.

Area of Science:

  • Health economics
  • Pharmaceutical policy

Background:

  • Healthcare systems face rising drug costs.
  • Ensuring access to effective drugs without financial unsustainability is a challenge.

Discussion:

  • Effective fiscal management requires understanding affordability before implementing policies.
  • A public agency's experience in New Zealand highlights the benefits of budget constraints in achieving health outcomes.

Key Insights:

  • Budgetary constraints are a more proactive and effective tool for managing healthcare spending than solely relying on improved information.
  • Prioritizing financial capacity is crucial for sustainable healthcare systems.

Outlook:

  • Future policies should integrate financial planning with regulatory improvements.

Related Experiment Videos

  • Exploring budget-constrained models for drug subsidy allocation is recommended for fiscal sustainability.